Domark International (DOMK) 10-Q 14 Jan 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Nov. 30, 2013
Document And Entity Information	'
Entity Registrant Name	'Domark International Inc.
Entity Central Index Key	'0001365160
Document Type	'10-Q
Document Period End Date	30-Nov-13
Amendment Flag	'false
Current Fiscal Year End Date	'--05-31
Is Entity a Well-known Seasoned Issuer?	'No
Is Entity a Voluntary Filer?	'No
Is Entity's Reporting Status Current?	'Yes
Entity Filer Category	'Smaller Reporting Company
Entity Common Stock, Shares Outstanding	100,204,129
Document Fiscal Period Focus	'Q2
Document Fiscal Year Focus	'2014

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Nov. 30, 2013	31-May-13
CURRENT ASSETS	'	'
Cash and cash equivalents	($38)	$20
Prepaid expenses	17,822	17,823
TOTAL CURRENT ASSETS	17,784	17,843
INVESTMENTS	932,459	'
OTHER ASSETS	'	'
Loan receivable from consultant	36,203	'
Patents	75,500	40,000
License, net of accumulated amortization of $2,548 and $1,828, respectively	7,462	8,182
TOTAL OTHER ASSETS	119,165	48,182
TOTAL ASSETS	1,069,408	66,025
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	'	'
Accounts payable & accrued expenses	241,482	209,179
Loans payable to consultants and stockholders	207,995	45,288
Convertible notes payable (net of unamortized discounts of $385,981 and $59,301, respectively)	71,196	148,691
Derivative liability for convertible notes payable	697,572	237,578
TOTAL CURRENT LIABILITIES AND TOTAL LIABILITIES	1,218,245	640,736
STOCKHOLDERS' EQUITY (DEFICIT)	'	'
Preferred stock, $0.001 par value, authorized 10,000,000 shares: Series A convertible preferred stock - issued and outstanding 50,000 shares	50	50
Common stock, $0.001 par value, authorized 200,000,000 shares: issued and outstanding 100,204,129 and 54,615,298 shares, respectively	100,204	54,615
Common stock payable	858,000	858,000
Additional paid-in capital	42,479,869	40,816,440
Accumulated deficit	-26,850,830	-26,850,830
Accumulated deficit during development stage	-16,736,130	-15,452,986
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	-148,837	-574,711
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$1,069,408	$66,025

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Nov. 30, 2013	31-May-13
Consolidated Balance Sheets Parenthetical	'	'
License, net of accumulated amortization	$2,548	$1,828
Convertible notes payable net of unamortized discounts	$385,981	$59,301
STOCKHOLDERS' EQUITY (DEFICIT)	'	'
Preferred stock series A, par value	$0.00	$0.00
Preferred stock series A, shares authorized	10,000,000	10,000,000
Preferred stock series A, shares issued	50,000	50,000
Preferred stock series A, shares outstanding	50,000	50,000
Common Stock, par value	$0.00	$0.00
Common Stock, shares authorized	200,000,000	200,000,000
Common Stock, shares issued	100,204,129	54,615,298
Common Stock, shares outstanding	100,204,129	54,615,298

Consolidated_Statements_Of_Ope

Consolidated Statements Of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended		49 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013
Consolidated Statements Of Operations	'	'	'	'	'
Sales	'	$16,193	'	$36,538	$57,864
Cost of sales	'	6,164	'	29,141	80,284
Gross profit	'	10,029	'	7,397	-22,420
Operating expenses:	'	'	'	'	'
General and administrative	259,559	178,618	519,002	539,267	2,191,884
Stock-based compensation	59,850	296,911	513,675	707,491	7,381,191
Research and development	'	'	'	'	45,609
Amortization of Barefoot-Science license fee	'	500,000	'	894,520	1,394,520
Impairment of Barefoot-Science license fee	'	'	'	'	4,605,480
Depreciation expense	360	364	720	2,983	15,261
Impairment of other assets	'	'	'	'	20,000
Bad debt expenses	'	456	'	1,456	101,456
Loss (income) on settlement of debt	'	-24,197	'	-24,197	409,903
Total operating expenses	319,769	952,152	1,033,397	2,121,520	16,165,304
Loss from operations	-319,769	-942,123	-1,033,397	-2,114,123	-16,187,724
Other income (expense):	'	'	'	'	'
Other income	'	'	'	'	29,567
Revaluation of derivative liability for convertible notes	-176,720	'	-161,744	'	-399,322
Interest expense	-23,045	-20,231	-88,003	-35,030	-178,651
Total other income (expense)	-199,765	-20,231	-249,747	-35,030	-548,406
Net loss	($519,534)	($962,354)	($1,283,144)	($2,149,153)	($16,736,130)
Net loss per common share, basic and diluted	($0.01)	($0.03)	($0.02)	($0.07)	'
Weighted average common shares outstanding	87,316,592	29,540,298	75,919,384	29,508,922	'

Consolidated_Statements_Of_Cas

Consolidated Statements Of Cash Flows (Unaudited) (USD $)	6 Months Ended		49 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES	'	'	'
Net Loss	($1,283,144)	($2,149,153)	($16,736,130)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'
Depreciation and amortization	720	2,983	15,261
Amortization of deferred finance costs	'	24,799	60,000
Common stock issued as compensation	513,675	707,461	7,381,191
Non cash interest	88,003	'	93,648
Loss (gain) on derivative valuation	161,744	'	399,322
Amortization of prepaid license fees	'	894,520	1,394,520
Impairment of assets	'	'	4,615,480
Loss (income) on settlement of debt	'	-24,197	409,903
Changes in Operating assets and liabilities:	'	'	'
Inventory - tv production	'	'	-16,926
Prepaid expenses	1	605	-12,925
Accounts payable and accrued expenses	32,303	330,777	410,787
Accounts payable -related party	'	8,831	15,366
Net cash used in operating activities	-486,698	-203,374	-1,970,503
CASH FLOWS FROM INVESTING ACTIVITIES	'	'	'
Cash paid for licensing	'	'	-35,000
Cash paid for furniture & equipment	'	'	-4,000
Cash Paid for web development	'	'	-7,500
Cash paid for investments	-134,149	'	-134,149
Cash paid for loan receivable from consultant	-36,203	'	-36,203
Net cash used in investing activities	-170,352	'	-216,852
CASH FLOWS FROM FINANCING ACTIVITIES	'	'	'
Proceeds from convertible notes payable	442,500	'	552,500
Proceeds from loans payable to consultants and stockholders	224,499	158,437	1,312,187
Payments made on loans payable to consultants and stockholders	-10,007	-1,000	-136,485
Proceeds received from notes payable	'	'	556,058
Payments made on notes payable	'	'	-100,470
Net cash provided by financing activities	656,992	157,437	2,183,790
Net increase(decrease) in cash and cash equivalants	-58	-45,937	-3,565
CASH BALANCE BEGINNING OF PERIOD	20	52,269	3,527
CASH BALANCE END OF PERIOD	-38	6,332	-38
Cash paid for interest	'	'	'
Cash paid for taxes	'	'	'
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:	'	'	'
Prepaid licensing fee	'	6,000,000	6,000,000
Shares issued for settlement of loans payable to consultants and stockholders	52,500	'	52,500
Shares issued for settlement of convertible notes payable	272,362	'	420,362
Shares issued for patent acquisition	35,500	'	75,500
Shares issued for 19% equity interest in Imagic Ltd	$697,500	'	$697,500

Description_of_Business

Description of Business	6 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 1 - Description of Business	'
	DOMARK INTERNATIONAL, INC. ("DoMark" or the "Company") was incorporated under the laws of the State of Nevada on March 30, 2006. During 2008 and 2009, the Company acquired several operating businesses. On May 21, 2009, the Company entered into an acquisition agreement (the "Victory Lane Agreement") with Victory Lane Financial Elite, LLC ("Victory Lane") with respect to a real estate lifestyle business known as "Victory Lane" (the "Victory Lane Business"). Shortly thereafter, a dispute arose between the Company and the principals of Victory Lane regarding the representations of the principals of Victory Lane and the Victory Lane Business and the Victory Lane Agreement.
	On March 5, 2012, the Company entered into an Asset Purchase Agreement with its then controlling shareholder, R. Thomas Kidd, for the sale of the Company’s subsidiary Armada Armada/The Golf Championships and certain assets related thereto. The Company relied upon Accounting Standards Codification (“ASC”) Topic NO5, 860-20-25 and 860-20-40 to record the sale. The fair value of the transaction was measured at the fair value of the assets less any liabilities sold.
	On February 29, 2012, the Company formed a new wholly owned subsidiary, Solawerks, Inc. in the state of Nevada, for the purposes of entering the business of marketing specialized solar consumer electronics. Solawerks' current focus is to develop and distribute the SolaPad: a combined cover and charging system for Apple's iPad; and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone. Solawerks competes in a market that also includes 3D Systems (DDD), Dell (DELL) and Hewlett Packard (HPQ).
	On June 20, 2012, the Company formed a new wholly-owned subsidiary, MuscleFoot Inc. in the state of Nevada for the purpose of distributing, marketing, and acting as sales agent for the patented foot care system of Barefoot Science. This entity is currently in default with the Nevada Secretary of State.
	On July 20, 2012, the Company formed a new wholly-owned subsidiary, DoMark Canada Inc. in the province of Ontario for the purpose of supporting the Company’s corporate operations based in Toronto, Ontario, Canada.
	On February 28, 2013, the Company entered into a Memorandum of Understanding to purchase 44% of Zaktek Ltd. (“Zaktek”).  Zaktek’s main product is the phonepad+, an Apple Inc. approved tablet device that works with smartphones, including the Apple iPhone® and Samsung Galaxy products to improve functionality including video and gaming abilities.
	On April 23, 2013, the Company received notification that Zaktek was ending discussions in regards to the definitive purchase agreement with DoMark.
	On June 11, 2013, the Company then purchased 100% of South Hill Ltd., an English private limited company, which owns approximately 19% of Zaktek.

Going_Concern

Going Concern	6 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 2 - Going Concern	'
	The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America which contemplate continuation of the Company as a going concern. For the period October 21, 2009 (inception of development stage) to November 30, 2013, the Company incurred losses from operations of $16,187,724. Furthermore, the Company has inadequate working capital to maintain or develop its operations, and is dependent upon funds from private investors and the support of certain stockholders.
	These factors raise substantial doubt about the ability of the Company to continue as a going concern. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. In this regard, management is planning to raise any necessary additional funds through loans and additional sales of its common stock. There is no assurance that the Company will be successful in raising additional capital.

Basis_of_Presentation

Basis of Presentation	6 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 3 - Basis of Presentation	'
	The audited consolidated financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles ("GAAP") for financial information and the rules and regulations of the Securities and Exchange Commission ("SEC"). In the opinion of management, all adjustments, consisting of normal recurring accruals considered necessary for a fair presentation, have been included.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	6 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 4 - Summary of Significant Accounting Policies	'
	RECENT ACCOUNTNG PRONOUNCEMENTS
	The Company has reviewed recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.
	DEVELOPMENT STAGE COMPANY
	The Company is a development stage company as defined in ASC Topic NO. 915-10-05 and has recognized minimal revenue and devotes substantially all of its efforts on consumer electronic businesses. Its planned principal operations in developing its sports business have commenced. All losses accumulated since October 21, 2009 have been considered as part of the Company's development stage activities.
	PRINCIPLES OF CONSOLIDATION
	The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the active entity of DoMark International, Inc. and its wholly owned subsidiaries, DoMark Canada, Inc., Solawerks, Inc., Musclefoot, Inc., and South Hill Ltd. The Company has relied upon the guidance provided by ASC Topic NO.810-10-15-3.
	USE OF ESTIMATES
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.
	The primary management estimates included in these financial statements are the fair value of its stock tendered in various non-monetary transactions.
	CASH AND CASH EQUIVALENTS
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At November 30 and May 31, 2013, cash and cash equivalents included cash on hand and cash in the bank.
	NET LOSS PER COMMON SHARE
	Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially outstanding shares of common stock during each period. Dilutive securities having an anti-dilutive effect on diluted net loss per common share are excluded from the calculation.
	For the six months ended November 30, 2013 and 2012, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive:
		Six Months Ended
		30-Nov
		2013		2012
	Convertible notes payable				-
	Series A convertible preferred stock		50,000,000		50,000,000
	Warrants		850,000		350,000
	Total				50,350,000
	INTANGIBLE ASSETS
	Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.
	IMPAIRMENT OF LONG-LIVED ASSETS
	In accordance with ASC Topic No. 360-10-40, long-lived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
	STOCK-BASED COMPENSATION
	The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective - Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.
	ASC Topic No. 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.
	RESEARCH AND DEVELOPMENT
	All research and development expenditures are expensed as incurred.
	REVENUE RECOGNITION
	The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

Investments

Investments	6 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 5 - Investments	'
	Investments consist of:
		November 30,		May 31,
		2013		2013
	Imagic Ltd. - 31% equity interest - at cost (7,500,000 shares of DoMark common stock - $697,500, cash -$120,194, loans payable -$100,000)	$	917,694	$	-
	Barefoot Science Products & Services Inc. - 15% equity interest		14,765		5,000
	Total	$	932,459	$	361,000
	On July 22, 2013, the Company closed on the acquisition of a 19% equity interest n Imagic Ltd. (“Imagic”). Imagic is a privately owned company registered in Gibraltar which owns proprietary product designs for its Digilink and Game Control products. Imagic shares are not quoted or traded on any securities exchange or in any recognized over-the counter market. Accordingly, it is not practicable to estimate the fair value of this investment.
	On January 25, 2013, the Company executed an agreement with Barefoot Science Products & Services Inc. (“Barefoot Science”) which cancelled the Marketing and Distribution Agreement dated June 20, 2012 and which provided the Company a 15% equity interest in Barefoot Science. As a result, the Company recognized an impairment charge of $4,605,480 in the year ended May 31, 2013 to write off the remaining unamortized prepaid license fees at February 28, 2013 ($4,605,480) and to record the estimated fair value of the 15% equity interest in Barefoot Science at $5,000. Barefoot Science has developed a patented foot strengthening system through insertion of an insole system or by incorporation right into the design of shoes. Barefoot Science shares are not quoted or traded on any securities exchange or in any recognized over-the counter market. Accordingly, it is not practicable to estimate the fair value of this investment.

Loans_Payable_to_Consultants_a

Loans Payable to Consultants and Stockholders	6 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
NOTE 6 - Loans Payable to Consultants and Stockholders	'
	Loans payable to consultants and stockholders consist of:
		November 30,		May 31,
		2013		2013
	Consultant and stockholder		79,800		7,800
	Former chairman of DoMark		49,000		-
	Chairman of Barefoot Science and affiliate		33,500		-
	Consultant		26,996		-
	Consultant		16,097		37,488
	Consultant		2,602		-
	Total	$	207,995	$	29,088
	The loans are informal and do not provide for interest or a stated maturity date.

Convertible_Notes_Payable

Convertible Notes Payable	6 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 7 - Convertible Notes Payable	'
	At November 30, 2013, convertible notes payable consisted of
	Date of		Noteholder		Interest				Maturity		Principal			Unamortized Debt Discount		Net Carrying Amount
	Note				Rate				date		Amount
	6/11/13		Asher Enterprises, Inc.			8	%		3/3/14			32,500	(a)		19,560		12,940
	8/1/13		Continental Equities, LLC			12	%		8/1/14			30,000	(b)		28,550		1,450
	8/5/13		JSJ Investments, Inc.			10	%		2/5/14			25,000	(c)		24,811		189
	8/7/13		JMJ Financial Inc.			12	%		8/7/14			50,000	(d)		28,610		21,390
	8/13/13		Black Mountain Equities, Inc.			10	%		5/13/14			50,000	(e)		41,152		8,848
	8/26/13		Redwood Fund III			12	%		2/28/14			95,000	(f)		92,334		2,666
	9/10/13		Asher Enterprises, Inc.			8	%		6/10/14			32,500	(a)		32,353		147
	10/9/13		JSJ Investments, Inc.			10	%		4/9/14			25,000			24,234		766
	10/31/13		Iconic Holdings, LLC			10	%		10/31/14			30,000			29,955		45
	10/31/13		Iconic Holdings, LLC			10	%		10/31/14			14,677			101		14,576
	11/8/13		Iconic Holdings, LLC			10	%		11/8/14			30,000			29,955		145
	11/26/13		Asher Enterprises, Inc.			8	%		8/26/14			42,500			34,366		8,134
	Totals										$	457,177		$	385,981	$	71,196
	Legend
	(a)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 55% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
	(b)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 50% of the average of the three lowest closing prices during the 30 trading days prior to the notice of conversion.
	(c)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion.
	(d)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.085 or 60% of the lowest closing price during the 25 trading days prior to the notice of conversion.
	(e)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.08 or 50% of the lowest closing price during the 10 trading days prior to the notice of conversion.
	(f)	At noteholder’s option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.0725 or 34% of the lowest closing price during the 20 trading days prior to the notice of conversion.
	(g)	At noteholder’s option, the principal amount (and accrued interest) are co
	At August 31, 2013 and May 31, 2013, accrued interest payable on convertible notes payable (included in accounts payable and accrued expenses) was $0 and $0, respectively.
	For the three months ended August 31, 2013, interest expense includes accretion of debt discounts (relating to beneficial conversion features) on convertible notes payable of $3,518.
	Derivative Liability for Convertible Notes Payable
	The convertible notes issued in 2013 (with a total principal amount of $354,000) all contain a provision that the conversion price is to be reduced in the event that we are deemed to have sold or issued any shares of common stock for a consideration price per share less than the conversion price. Accordingly, in accordance with EITF Issue No. 07-05, “Determining Whether an Instrument (or Embedded Feature) is Indexed to an Entity’s Own Stock”, we charged the option value of these convertible notes at the respective dates of issuance (totaling $544,962) to debt discounts for the intrinsic value of the embedded beneficial conversion features (limited to the principal amount of the notes) in these notes (totaling $330,196), which are expensed over the terms of the respective notes to increase the carrying values to principal amounts, and to “income (loss) from revaluation of derivative liability for convertible notes” ($214,766) and credited $544,962 to “derivative liability for convertible notes payable”. Each quarter, the option value of these convertible notes is remeasured and changes are reflected within the “Statement of Operations” as “income (loss) from revaluation of derivative liability for convertible notes”. Option values were calculated using the Black-Scholes option pricing model and the following assumptions: Stock prices ranging from $________to $________ per share, strike prices ranging from $________ to $________ per share; risk-free interest rates ranging from __% to __%, terms ranging from ___days to ___days, and expected volatility ranging from ___% to ___%.
	Below is a reconciliation of the change in option values from January 30, 2013 to August 31, 2013:
				Principal Amount of Convertible Note Payable				Option
								Value
	Issuance of convertible notes with EITF 07-05 provision:
	January 30,2013	($17,256 charged to operations)		$	53,000			$	67,256
	15-Apr-13	($9,717charged to operations)			32,500				37,658
	Total				85,500				104,914
	Revaluation of derivative liability charged (credited) to operations:
	Three months ended February 28, 2013				-				-
	Three months ended May 31, 2013				-				132,664
	Total				-				132,664
	Balance, May 31, 2013:				85,500				237,578
	Issuance of convertible notes with EITF 07-05 provision:
	11-Jun-13	($6,647 charged to operations)			32,500				38,359
	1-Aug-13	($7,703 charged to operations)			30,000				37,672
	5-Aug-13	($6,998 charged to operations)			25,000				31,967
	7-Aug-13	($30,500 charged to operations)			50,000				63,788
	13-Aug-13	($36,359 charged to operations)			50,000				81,818
	26-Aug-13	($91,454 charged to operations)			95,000				186,444
	Total				282,500				440,048
	Conversion of $14,000 principal amount of January 30, 2013 $53,000 convertible note into 389,972 shares of common stock on August 28, 2013				(14,000	)			(13,727	)
	Revaluation of derivative liability charged (credited) to operations:
	Three months ended August 31, 2013				-				(143,046	)
	Balance, August 31, 2013			$	354,000			$	520,853

Stockholders_Equity

Stockholders Equity	6 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 8 - Stockholders Equity	'
	SERIES A CONVERTIBLE PREFERRED STOCK
	EACH SHARE OF Series A Convertible Stock has 1000 voting rights and is convertible into 1000 shares of common stock
	COMMON STOCK ISSUANCES
	On September 18, 2013, the Company issued 856,164 shares of common stock in satisfaction of $14,500 loan payable
	On October 9, 2013, the Company issued 1,000,000 shares of common stock for consulting services
	On October 10, 2013, the Company issued 250,000 shares of common stock for consulting services
	On November 4, 2013, the Company issued 903,261 shares of common stock in satisfaction of $14,750 of loan payable
	On November 4, 2013, the Company issued 1,153,846 shares of common stock in satisfaction of $33,750 loan payable
	On November 4, 2013, the Company issued 3,500,000 shares of common stock in satisfaction of $52,500 loan payable
	On November 12, 2013, the Company issued 1,630,435 shares of common stock in satisfaction of $18,750 loan payable
	On November 14, 2013, the Company issued 3,999,200 shares of common stock in satisfaction of $13,197 loan payable
	On November 15, 2013, the Company issued 175,000 shares of common stock for consulting services
	On November 19, 2013, the Company issued 3,456,597 shares of common stock in satisfaction of $18,750 loan payable
	On November 19, 2013, the Company issued 8,850,572 shares of common stock in satisfaction of $27,874 loan payable
	Warrants to Purchase Common Stock
	A summary of warrant activity for the year ended May 31, 2013 and for the  six months ended November 30, 2013 follows:
				Weighted
		Number of		Average Exercise
		Warrants		Price
	Outstanding at May 31, 2013		850,000		0.42
	Granted		-		-
	Exercised		-		-
	Cancelled		-		-
	Outstanding at May 31, 2013		850,000		0.42
	Granted		-		0.42
	Exercised		-		-
	Cancelled		-		-
	Outstanding November 30, 2013		850,000		0.42
	Warrants outstanding at November 30, 2013 consist of:
		#		Exercise		Expiration
		of outstanding		Price		Date
	Date Granted
	25-May-12		100,000		1	25-May-15
	12-Jun-12		150,000		1	12-Jun-15
	26-Jun-12		100,000		1	26-Jun-15
	13-Jan-13		500,000		1	1-Jan-15
	Totals		850,000

Commitments_and_Contingencies

Commitments and Contingencies	6 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 9 - Commitments and Contingencies	'
	License Agreements
	On February 29, 2012 , the Company entered into a memorandum of Agreement with Xiamen Taiyang Neng Gongsi and Michael Franklin. For and in consideration of the payment of an license fee of $10,000, and for the future payment of royalties of $5.00 per SolaPad unit sold, Xiamen granted an exclusive worldwide license and joint patent rights to the Company for a solar charging case for IPAD, including IPAD 3. The license under the Agreement expires December31, 2018
	On April 19, 2013, our subsidiary DoMark Canad, Inc. executed an agreement with Bioharmonics Technologies Cop ( “Bioharmonics”0. The agreement provided for the acquisition of certain inventions and related patents and patent applications in exchange for 500,000 shares of Domark common stock ( which was delivered April 19, 2013 and valued at $40,000) and $30,000 cash payable no later than October 17, 2013 ( which was satisfied through delivery of an additional 500,000 shares of Domark common stock to Bioharmonics on August 15, 2013 valued at $35,500) The agreement also provides for a royalty obligation to Bioharmonics equal to 10% of the wholesale price for each unit using the infrared solar charging.
	Employment Agreements
	On May 25, 2012, the Company entered into an employment agreement with its non exec chairman, Brent Strassler, for an indefinite period or until terminated. Mr. Strassler is entitles to an annual salary of $150,000 and 100,000 stock purchase warrants exercisable to purchase common stock of the Company at $1.00 per share. The warrants are exercisable for a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally, Mr. Strassler is to be enrolled in a long term Executive Option Plan and is entitled to term life insurance in the face amount of $2,500,000, payable to the beneficiary designated by Mr. Strassler.
	On June 15, 2012, the Company entered into an employment agreement with its Chief Executive Officer Andrew Ritchie, for an indefinite period or until terminated. Mr Ritchie is entitled to an annual salary of $240,000, and 150,000 stock purchase warrants exercisable to purchase shares of common stock of the Company at $1.00 per share. The warrants are exercisable over a three year period and can be vested quarterly on a pro rata basis over twelve months from the date of issue. Additionally Mr. Ritchie is to be enrolled in a long term Executive option Plan and is entitled to a term life insurance in the face amount of $2,500,000 payable to the beneficiary designated by Mr. Ritchie.
	Lease Agreement
	On August 1,2013 the Company entered into an office lease in Toronto, Ontario, Canada for a five year period. The future lease commitments on this lease are as follows for the years ended May 31:
	May-14	$	31,500
	May-15	$	54,000
	May-16	$	54,000
	May-17	$	54,000
	May-18	$	31,500
	Total	$	225,000

Subsequent_Events

Subsequent Events	6 Months Ended
	Nov. 30, 2013
Notes to Financial Statements	'
Note 10 - Subsequent Events	'
	On December 3, 2013, the Company issued 8,000,000 shares of common stock (valued at $180,000) to Meadow Grove Ltd. in connection with the acquisition of an additional 9% equity interest in Imagic Ltd. (increasing its ownership to a 40% equity interest). See Note 5.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Nov. 30, 2013
Summary Of Significant Accounting Policies Policies	'
Recent Accountng Pronouncements	'
	The Company has reviewed recently issued accounting pronouncements and plans to adopt those that are applicable to it. It does not expect the adoption of these pronouncements to have a material impact on its financial position, results of operations or cash flows.
Development Stage Company	'
	The Company is a development stage company as defined in ASC Topic NO. 915-10-05 and has recognized minimal revenue and devotes substantially all of its efforts on consumer electronic businesses. Its planned principal operations in developing its sports business have commenced. All losses accumulated since October 21, 2009 have been considered as part of the Company's development stage activities.
Principles of Consolidation	'
	The accompanying consolidated financial statements represent the consolidated financial position and results of operations of the Company and include the accounts and results of operations of the Company and its subsidiaries. The accompanying consolidated financial statements include the active entity of DoMark International, Inc. and its wholly owned subsidiaries, DoMark Canada, Inc., Solawerks, Inc., Musclefoot, Inc., and South Hill Ltd. The Company has relied upon the guidance provided by ASC Topic NO.810-10-15-3.
Use of Estimates	'
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. These estimates and assumptions also affect the reported amounts of revenues, costs and expenses during the reporting period. Management evaluates these estimates and assumptions on a regular basis. Actual results could differ from those estimates.
	The primary management estimates included in these financial statements are the fair value of its stock tendered in various non-monetary transactions.
Cash and Cash Equivalents	'
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At November 30 and May 31, 2013, cash and cash equivalents included cash on hand and cash in the bank.
Net Loss Per Common Share	'
	Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially outstanding shares of common stock during each period. Dilutive securities having an anti-dilutive effect on diluted net loss per common share are excluded from the calculation.
	For the six months ended November 30, 2013 and 2012, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive:
		Six Months Ended
		30-Nov
		2013		2012
	Convertible notes payable				-
	Series A convertible preferred stock		50,000,000		50,000,000
	Warrants		850,000		350,000
	Total				50,350,000
Intangible Assets	'
	Intangible assets are carried at cost less accumulated amortization. Amortization is recorded over the estimated useful lives of the respective assets.
Impairment of Long-Lived Assets	'
	In accordance with ASC Topic No. 360-10-40, long-lived assets, such as property, plant, and equipment, and purchased intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment annually. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Stock Based Compensation	'
	The Company accounts for share based payments in accordance with ASC Topic No. 718, Compensation - Stock Compensation, which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on the grant date fair value of the award. In accordance with ASC 718-10-30-9, Measurement Objective - Fair Value at Grant Date, the Company estimates the fair value of the award using a valuation technique. For stock options, the Company uses the Black-Scholes option pricing model. The Company believes this model provides the best estimate of fair value due to its ability to incorporate inputs that change over time, such as volatility and interest rates, and to allow for actual exercise behavior of option holders. Compensation cost is recognized over the requisite service period which is generally equal to the vesting period. Upon exercise, shares issued will be newly issued shares from authorized common stock.
	ASC Topic No. 505, "Compensation-Stock Compensation", establishes standards for the accounting for transactions in which an entity exchanges its equity instruments to non-employees for goods or services. Under this method, stock compensation expense includes compensation expense for all stock-based compensation awards granted on or after January 1, 2006, based on the grant-date fair value estimated in accordance with the provisions of ASC 505.
Research and Development	'
	All research and development expenditures are expensed as incurred.
Revenue Recognition	'
	The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery and acceptance has occurred or service has been rendered, the price is fixed or determinable, and collection of the resulting receivable is reasonably assured.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Nov. 30, 2013
Summary Of Significant Accounting Policies Tables	'
Net Loss Per Common Share	'
	For the six months ended November 30, 2013 and 2012, diluted common shares outstanding excluded the following dilutive securities as the effect of their inclusion was anti-dilutive:
		Six Months Ended
		30-Nov
		2013		2012
	Convertible notes payable				-
	Series A convertible preferred stock		50,000,000		50,000,000
	Warrants		850,000		350,000
	Total				50,350,000

Investments_Tables

Investments (Tables)	6 Months Ended
	Nov. 30, 2013
Investments Tables	'
Investments	'
	Investments consist of:
		November 30,		May 31,
		2013		2013
	Imagic Ltd. - 31% equity interest - at cost (7,500,000 shares of DoMark common stock - $697,500, cash -$120,194, loans payable -$100,000)	$	917,694	$	-
	Barefoot Science Products & Services Inc. - 15% equity interest		14,765		5,000
	Total	$	932,459	$	361,000

Loans_Payable_to_Consultants_a1

Loans Payable to Consultants and Stockholders (Tables)	6 Months Ended
	Nov. 30, 2013
Loans Payable To Consultants And Stockholders Tables	'
Loans payable to consultants and stockholders	'
	Loans payable to consultants and stockholders consist of:
		November 30,		May 31,
		2013		2013
	Consultant and stockholder		79,800		7,800
	Former chairman of DoMark		49,000		-
	Chairman of Barefoot Science and affiliate		33,500		-
	Consultant		26,996		-
	Consultant		16,097		37,488
	Consultant		2,602		-
	Total	$	207,995	$	29,088

Convertible_Notes_Payable_Tabl

Convertible Notes Payable (Tables)	6 Months Ended
	Nov. 30, 2013
Convertible Notes Payable Tables	'
Convertible notes payable	'
	At November 30, 2013, convertible notes payable consisted of
	Date of		Noteholder		Interest				Maturity		Principal			Unamortized Debt Discount		Net Carrying Amount
	Note				Rate				date		Amount
	6/11/13		Asher Enterprises, Inc.			8	%		3/3/14			32,500	(a)		19,560		12,940
	8/1/13		Continental Equities, LLC			12	%		8/1/14			30,000	(b)		28,550		1,450
	8/5/13		JSJ Investments, Inc.			10	%		2/5/14			25,000	(c)		24,811		189
	8/7/13		JMJ Financial Inc.			12	%		8/7/14			50,000	(d)		28,610		21,390
	8/13/13		Black Mountain Equities, Inc.			10	%		5/13/14			50,000	(e)		41,152		8,848
	8/26/13		Redwood Fund III			12	%		2/28/14			95,000	(f)		92,334		2,666
	9/10/13		Asher Enterprises, Inc.			8	%		6/10/14			32,500	(a)		32,353		147
	10/9/13		JSJ Investments, Inc.			10	%		4/9/14			25,000			24,234		766
	10/31/13		Iconic Holdings, LLC			10	%		10/31/14			30,000			29,955		45
	10/31/13		Iconic Holdings, LLC			10	%		10/31/14			14,677			101		14,576
	11/8/13		Iconic Holdings, LLC			10	%		11/8/14			30,000			29,955		145
	11/26/13		Asher Enterprises, Inc.			8	%		8/26/14			42,500			34,366		8,134
	Totals										$	457,177		$	385,981	$	71,196
Reconciliation of the change in option values	'
	Below is a reconciliation of the change in option values from January 30, 2013 to August 31, 2013:
				Principal Amount of Convertible Note Payable				Option
								Value
	Issuance of convertible notes with EITF 07-05 provision:
	January 30,2013	($17,256 charged to operations)		$	53,000			$	67,256
	15-Apr-13	($9,717charged to operations)			32,500				37,658
	Total				85,500				104,914
	Revaluation of derivative liability charged (credited) to operations:
	Three months ended February 28, 2013				-				-
	Three months ended May 31, 2013				-				132,664
	Total				-				132,664
	Balance, May 31, 2013:				85,500				237,578
	Issuance of convertible notes with EITF 07-05 provision:
	11-Jun-13	($6,647 charged to operations)			32,500				38,359
	1-Aug-13	($7,703 charged to operations)			30,000				37,672
	5-Aug-13	($6,998 charged to operations)			25,000				31,967
	7-Aug-13	($30,500 charged to operations)			50,000				63,788
	13-Aug-13	($36,359 charged to operations)			50,000				81,818
	26-Aug-13	($91,454 charged to operations)			95,000				186,444
	Total				282,500				440,048
	Conversion of $14,000 principal amount of January 30, 2013 $53,000 convertible note into 389,972 shares of common stock on August 28, 2013				(14,000	)			(13,727	)
	Revaluation of derivative liability charged (credited) to operations:
	Three months ended August 31, 2013				-				(143,046	)
	Balance, August 31, 2013			$	354,000			$	520,853

Stockholders_Equity_Tables

Stockholders Equity (Tables)	6 Months Ended
	Nov. 30, 2013
Stockholders Equity Tables	'
Summary of warrant activity	'
	A summary of warrant activity for the year ended May 31, 2013 and for the  six months ended November 30, 2013 follows:
				Weighted
		Number of		Average Exercise
		Warrants		Price
	Outstanding at May 31, 2013		850,000		0.42
	Granted		-		-
	Exercised		-		-
	Cancelled		-		-
	Outstanding at May 31, 2013		850,000		0.42
	Granted		-		0.42
	Exercised		-		-
	Cancelled		-		-
	Outstanding November 30, 2013		850,000		0.42
Warrants outstanding	'
	Warrants outstanding at November 30, 2013 consist of:
		#		Exercise		Expiration
		of outstanding		Price		Date
	Date Granted
	25-May-12		100,000		1	25-May-15
	12-Jun-12		150,000		1	12-Jun-15
	26-Jun-12		100,000		1	26-Jun-15
	13-Jan-13		500,000		1	1-Jan-15
	Totals		850,000

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	6 Months Ended
	Nov. 30, 2013
Commitments And Contingencies Tables	'
Future Lease Commitments	'
	August 1,2013 the Company entered into an office lease in Toronto, Ontario, Canada for a five year period. The future lease commitments on this lease are as follows for the years ended May 31:
	May-14	$	31,500
	May-15	$	54,000
	May-16	$	54,000
	May-17	$	54,000
	May-18	$	31,500
	Total	$	225,000

Going_Concern_Details_Narrativ

Going Concern (Details Narrative) (USD $)	49 Months Ended
	Nov. 30, 2013
Going Concern Details Narrative	'
Loss from operation	$16,187,724

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details)	6 Months Ended
	Nov. 30, 2013	Nov. 30, 2012
Summary Of Significant Accounting Policies Details	'	'
Convertible notes payable	'	'
Series A convertible preferred stock	50,000,000	50,000,000
Warrants	850,000	350,000
Total	'	50,350,000

Investments_Details

Investments (Details) (USD $)	Nov. 30, 2013	31-May-13
Investments Details	'	'
Imagic Ltd. - 31% equity interest - at cost (7,500,000 shares of DoMark common stock - $697,500, cash -$120,194, loans payable -$100,000)	$917,694	'
Barefoot Science Products & Services Inc. - 15% equity interest	14,765	5,000
Total	$932,459	'

Investments_Details_Narrative

Investments (Details Narrative) (USD $)	3 Months Ended		6 Months Ended		12 Months Ended	49 Months Ended
	Nov. 30, 2013	Nov. 30, 2012	Nov. 30, 2013	Nov. 30, 2012	31-May-13	Nov. 30, 2013
Investments Details Narrative	'	'	'	'	'	'
Impairment charge	'	'	'	'	$4,605,480	$4,605,480

Loans_Payable_to_Consultants_a2

Loans Payable to Consultants and Stockholders (Details) (USD $)	Nov. 30, 2013	31-May-13
Loans payable to consultants and stockholders	$207,995	$29,088
Consultant And Stockholder [Member]	'	'
Loans payable to consultants and stockholders	79,800	7,800
Chairman of DoMark [Member]	'	'
Loans payable to consultants and stockholders	49,000	'
Chairman Of Barefoot Science And Affiliate [Member]	'	'
Loans payable to consultants and stockholders	33,500	'
Consultant [Member]	'	'
Loans payable to consultants and stockholders	26,996	'
Consultant One [Member]	'	'
Loans payable to consultants and stockholders	16,097	37,488
Consultant Two [Member]	'	'
Loans payable to consultants and stockholders	$2,602	'

Convertible_Notes_Payable_Deta

Convertible Notes Payable (Details) (USD $)	Nov. 30, 2013		31-May-13
Principal Amount	$457,177		'
Unamortized Debt Discount	385,981		59,301
Net Carrying Amount	71,196		148,691
Asher Enterprises Inc. [Member]	'		'
Date of Note	'2013-06-11		'
Interest Rate	8.00%		'
Maturity date	'2014-03-03		'
Principal Amount	32,500	[1]	'
Unamortized Debt Discount	19,560		'
Net Carrying Amount	12,940		'
Continental Equities LLC [Member]	'		'
Date of Note	'2013-08-01		'
Interest Rate	12.00%		'
Maturity date	'2014-08-01		'
Principal Amount	30,000	[2]	'
Unamortized Debt Discount	28,550		'
Net Carrying Amount	1,450		'
JSJ Investments Inc. [Member]	'		'
Date of Note	'2013-08-05		'
Interest Rate	10.00%		'
Maturity date	'2014-02-05		'
Principal Amount	25,000	[3]	'
Unamortized Debt Discount	24,811		'
Net Carrying Amount	189		'
JMJ Financial Inc. [Member]	'		'
Date of Note	'2013-08-07		'
Interest Rate	12.00%		'
Maturity date	'2014-08-07		'
Principal Amount	50,000	[4]	'
Unamortized Debt Discount	28,610		'
Net Carrying Amount	21,390		'
Black Mountain Equities Inc. [Member]	'		'
Date of Note	'2013-08-13		'
Interest Rate	10.00%		'
Maturity date	'2014-05-13		'
Principal Amount	50,000	[5]	'
Unamortized Debt Discount	41,152		'
Net Carrying Amount	8,848		'
Redwood Fund III [Member]	'		'
Date of Note	'2013-08-26		'
Interest Rate	12.00%		'
Maturity date	'2014-02-28		'
Principal Amount	95,000	[6]	'
Unamortized Debt Discount	92,334		'
Net Carrying Amount	2,666		'
Asher Enterprises Inc One [Member]	'		'
Date of Note	'2013-09-10		'
Interest Rate	8.00%		'
Maturity date	'2014-06-10		'
Principal Amount	32,500	[1]	'
Unamortized Debt Discount	32,353		'
Net Carrying Amount	147		'
JSJ Investments Inc. One [Member]	'		'
Date of Note	'2013-10-09		'
Interest Rate	10.00%		'
Maturity date	'2014-04-09		'
Principal Amount	25,000		'
Unamortized Debt Discount	24,234		'
Net Carrying Amount	766		'
Iconic Holdings, LLC [Member]	'		'
Date of Note	'2013-10-31		'
Interest Rate	10.00%		'
Maturity date	'2014-10-31		'
Principal Amount	30,000		'
Unamortized Debt Discount	29,955		'
Net Carrying Amount	45		'
Iconic Holdings, LLC One [Member]	'		'
Date of Note	'2013-10-31		'
Interest Rate	10.00%		'
Maturity date	'2014-10-31		'
Principal Amount	14,677		'
Unamortized Debt Discount	101		'
Net Carrying Amount	14,576		'
Iconic Holdings, LLC Two [Member]	'		'
Date of Note	'2013-11-08		'
Interest Rate	10.00%		'
Maturity date	'2014-11-08		'
Principal Amount	30,000		'
Unamortized Debt Discount	29,955		'
Net Carrying Amount	145		'
Asher Enterprises Inc. Two [Member]	'		'
Date of Note	'2013-11-26		'
Interest Rate	8.00%		'
Maturity date	'2014-08-26		'
Principal Amount	42,500	[1]	'
Unamortized Debt Discount	34,366		'
Net Carrying Amount	$8,134		'
[1]	(a) At noteholders option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 55% of the average of the two lowest closing prices during the 15 trading days prior to the notice of conversion.
[2]	(b) At noteholders option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to 50% of the average of the three lowest closing prices during the 30 trading days prior to the notice of conversion.
[3]	(c) At noteholders option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.081 or 50% of the average of the three lowest closing prices during the 10 trading days prior to the notice of conversion.
[4]	(d) At noteholders option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.085 or 60% of the lowest closing price during the 25 trading days prior to the notice of conversion.
[5]	(e) At noteholders option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.08 or 50% of the lowest closing price during the 10 trading days prior to the notice of conversion.
[6]	(f) At noteholders option, the principal amount (and accrued interest) are convertible into shares of DoMark common stock at a conversion price equal to the lower of $0.0725 or 34% of the lowest closing price during the 20 trading days prior to the notice of conversion.

Convertible_Notes_Payable_Deta1

Convertible Notes Payable (Details 1) (USD $)	3 Months Ended	4 Months Ended
	Aug. 31, 2013	31-May-13
Principal Amount of Convertible Note Payable [Member]	'	'
Issuance of convertible notes on January 30,2013	'	$53,000
Issuance of convertible notes on April 15, 2013	'	32,500
Issuance of convertible notes from January 30, 2013 to May 31, 2013	'	85,500
Revaluation of derivative liability charged for Three months ended February 28, 2013	'	'
Revaluation of derivative liability charged for Three months ended May 31, 2013	'	'
Revaluation of derivative liability charged from January 30, 2013 to May 31, 2013	'	'
Balance, May 31, 2013	'	85,500
Issuance of convertible notes on June 11, 2013	32,500	'
Issuance of convertible notes on August 1, 2013	30,000	'
Issuance of convertible notes on August 5, 2013	25,000	'
Issuance of convertible notes on August 7, 2013	50,000	'
Issuance of convertible notes on August 13, 2013	50,000	'
Issuance of convertible notes on August 26, 2013	95,000	'
Issuance of convertible notes from June 1, 2013 to August 31, 2013	282,500	'
Conversion of $14,000 principal amount of January 30, 2013 $53,000 convertible note into 389,972 shares of common stock on August 28, 2013	-14,000	'
Revaluation of derivative liability charged for Three months ended August 31, 2013	'	'
Balance, August 31, 2013	354,000	'
Option Value [Member]	'	'
Issuance of convertible notes on January 30,2013	'	67,256
Issuance of convertible notes on April 15, 2013	'	37,658
Issuance of convertible notes from January 30, 2013 to May 31, 2013	'	104,914
Revaluation of derivative liability charged for Three months ended February 28, 2013	'	'
Revaluation of derivative liability charged for Three months ended May 31, 2013	'	132,664
Revaluation of derivative liability charged from January 30, 2013 to May 31, 2013	'	132,664
Balance, May 31, 2013	'	237,578
Issuance of convertible notes on June 11, 2013	38,359	'
Issuance of convertible notes on August 1, 2013	37,672	'
Issuance of convertible notes on August 5, 2013	31,967	'
Issuance of convertible notes on August 7, 2013	63,788	'
Issuance of convertible notes on August 13, 2013	81,818	'
Issuance of convertible notes on August 26, 2013	186,444	'
Issuance of convertible notes from June 1, 2013 to August 31, 2013	440,048	'
Conversion of $14,000 principal amount of January 30, 2013 $53,000 convertible note into 389,972 shares of common stock on August 28, 2013	-13,727	'
Revaluation of derivative liability charged for Three months ended August 31, 2013	-143,046	'
Balance, August 31, 2013	$520,853	'

Shareholders_Equity_Details

Shareholders Equity (Details) (USD $)	6 Months Ended	12 Months Ended
	Nov. 30, 2013	31-May-13
Shareholders Equity Details	'	'
Outstanding Number of Warrants, Beginning Balance	850,000	850,000
Granted	'	'
Exercised	'	'
Cancelled	'	'
Outstanding Number of Warrants, Ending Balance	850,000	850,000
Weighted Average Exercise Price, Beginning Balance	$0.42	$0.42
Granted	$0.42	'
Exercised	'	'
Cancelled	'	'
Weighted Average Exercise Price, Ending Balance	$0.42	$0.42

Stockholders_Equity_Details_1

Stockholders Equity (Details 1) (USD $)	Nov. 30, 2013	31-May-13	31-May-12	Nov. 30, 2013	Aug. 31, 2013	Nov. 30, 2013	Nov. 30, 2013
				Warrant [Member]	Warrant One [Member]	Warrant Two [Member]	Warrant Three [Member]
Date Granted	'	'	'	25-May-12	12-Jun-12	26-Jun-12	13-Jan-13
Number Of Warrant Outstanding	850,000	850,000	850,000	100,000	150,000	100,000	500,000
Exercise price	'	'	'	$1	$1	$1	$1
Expiration Date	'	'	'	25-May-15	12-Jun-15	26-Jun-15	1-Jan-15

Shareholders_Equity_Details_Na

Shareholders Equity (Details Narrative) (USD $)	Nov. 30, 2013	31-May-13
Common Stock, shares issued	100,204,129	54,615,298
Sep 18, 2013 [Member]	'	'
Common Stock, shares issued	856,164	'
Loan payable	14,500	'
Oct 09, 2013 [Member]	'	'
Common Stock, shares issued	1,000,000	'
Oct 10, 2013 [Member]	'	'
Common Stock, shares issued	250,000	'
Nov 04, 2013 One [Member]	'	'
Common Stock, shares issued	903,261	'
Loan payable	14,750	'
Nov 04, 2013 Two [Member]	'	'
Common Stock, shares issued	1,153,846	'
Loan payable	33,750	'
Nov 04, 2013 Three [Member]	'	'
Common Stock, shares issued	3,500,000	'
Loan payable	52,500	'
Nov 12, 2013 [Member]	'	'
Common Stock, shares issued	1,630,435	'
Loan payable	18,750	'
Nov 14, 2013 [Member]	'	'
Common Stock, shares issued	3,999,200	'
Loan payable	13,197	'
Nov 15, 2013 [Member]	'	'
Common Stock, shares issued	175,000	'
Nov 19, 2013 One [Member]	'	'
Common Stock, shares issued	3,456,597	'
Loan payable	18,750	'
Nov 19, 2013 Two [Member]	'	'
Loan payable	8,850,572	'

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	31-May-13
Commitments And Contingencies Details	'
May-14	$31,500
May-15	54,000
May-16	54,000
May-17	54,000
May-18	31,500
Total	$225,000